Kopran Limited
KOPRAN
Rank in Stocks
#18069
Kopran Limited is a fully integrated pharmaceutical entity that manufactures... Kopran Limited is a fully integrated pharmaceutical entity that manufactures and distributes both active pharmaceutical ingredients (APIs) and finished drug products, serving markets in India and worldwide. Its extensive product portfolio includes a diverse array of dosage formats, such as tablets, capsules, dry powders, suspensions, and injectable solutions. The company's active pharmaceutical ingredients cater to a broad spectrum of therapeutic applications, encompassing macrolides, antibacterials, anticonvulsants, anti-hypertensives, anti-helminthics, antihistamines, anti-acne treatments, anti-infectives, urologicals, anti-thrombotics, antidiabetics, pain management, gastroenterology, and cardiovascular medications. Established in 1958, Kopran Limited maintains its corporate headquarters in Mumbai, India.
Share Price
$2.99
Last synced: 2026-11-12
Market Cap
$144.25M
Change (1 day)
6.32%
Change (1 year)
90.02%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Kopran Limited (KOPRAN)
Category
Healthcare
Operating Margin for Kopran Limited (KOPRAN)
Operating Margin as of November 2026 TTM: 14.11%
According to Kopran Limited's latest financial reports, its current operating margin (TTM) is 14.11%. At the end of 2025 the company had an operating margin of 26.12%.
Operating Margin history for Kopran Limited from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 14.11% | -45.98% |
| 2025 | 26.12% | 144.34% |
| 2024 | 10.69% | 31.65% |
| 2023 | 8.12% | -49.81% |
| 2022 | 16.18% | 6.24% |
| 2021 | 15.23% | 37.70% |
| 2020 | 11.06% | -4.49% |
| 2019 | 11.58% | 48.27% |
| 2018 | 7.81% | -3.34% |
| 2017 | 8.08% | 123.20% |
| 2016 | 3.62% | -130.14% |
| 2015 | -12.01% | -311.82% |
| 2014 | 5.67% | -33.06% |
| 2013 | 8.47% | 12.33% |
| 2012 | 7.54% | 25.04% |
| 2011 | 6.03% | 42.55% |
| 2010 | 4.23% | -195.49% |
| 2009 | -4.43% | -76.83% |
| 2008 | -19.12% | 87.82% |
| 2006 | -10.18% | -52.03% |
| 2005 | -21.22% | -3,889.29% |
| 2004 | 0.56% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 46.07% | -96.73% |
US
|
|
| 25.17% | -98.22% |
US
|
|
| 35.21% | -97.50% |
US
|
|
| 31.92% | -97.74% |
CH
|
|
| 13.64% | -99.03% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Kopran Limited's operating margin
What is Kopran Limited's operating margin?
Kopran Limited's operating margin is 14.11%, as of Nov 2026.
What was Kopran Limited's operating margin in 2025?
In 2025, Kopran Limited's operating margin was 26.12%, compared with 10.69% in 2024.
How has Kopran Limited's operating margin changed since 2020?
From 2020 to 2025, Kopran Limited's operating margin was highest in 2025 (26.12%) and lowest in 2023 (8.12%).
How does Kopran Limited's operating margin compare with similar companies?
Kopran Limited's operating margin (14.11%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Eli Lilly and Company, with 46.07%.